PulsioFlex Monitor

The flexible platform for advanced haemodynamic patient monitoring, able to be adapted to each patient’s individual needs, at any time.

Haemodynamic Monitoring at the Highest Level

Basics of haemodynamic monitoring


Monitoring cardio-circulatory function is of major importance in all intensive care patients. Monitoring with standard parameters: ECG non-invasive blood pressure and pulse oxymetry provides insufficient information for deciding on the adequacy of treatments. Only advanced haemodynamic monitoring with invasive measurement of cardiac output and its determinants (preload, afterload, contractility) as well as the quantification of pulmonary oedema allows for early goal directed therapy.

System Overview 

Setup

PulsioFlex is a flexible platform with intelligent visualisation for advanced haemodynamic patient monitoring.
Through modular expandability and the availability of our efficient monitoring technologies, the system is able to be adapted to each patient’s individual need at any time:

  • Meeting your information requirements
  • Matching your clinical setting (OR, ER, ICU)
  • Adapted to your patients risk level

Technical specifications are subject to change without further notice

Components

PiCCO

ProAQT

LiMON

CeVOX

PiCCO

Haemodynamic Monitoring at the highest level

Monitoring physiological parameters is essential for the goal directed management of critical care patients. Highly invasive monitoring methods have been established in clinical practice for many years, but are increasingly the centre of critical discussion. The PiCCO-Technology is the solution.

PiCCO-Technology is the easy, less invasive and cost-efficient tool for determining the main haemodynamic parameters of critically ill patients.

Clinical & Economic Benefits of PICCO 

  • Get the complete picture of the patient’s status
  • Improve Patient outcome
  • Long-term advanced monitoring (ACCURATE values)
  • Post-operative management of unstable intensive care patients
  • Diagnosis of pulmonary oedema in critically ill patients
  • Less complications due to less organ failure including renal insufficiency
  • Shorter time on mechanical ventilation
  • Shorter ICU-stay
  • Goal Directed Therapy (GDT)
  • The PiCCO-Technology combines arterial pulse contour analysis using the innovative PiCCO algorithm with precise calibration via transpulmonary thermodilution
  • Arterial access via femoral, brachial and axillary artery
  • Application in children / paediatrics with special 3 french PiCCO catheter possible

ProAQT®

Reliable interpretation of the patient‘s hemodynamic status in the OR.

ProAQT® is one component of the PulsioFlex monitoring concept. ProAQT® technology supports goal directed therapy and allows the review of interventions to assess their success. Within minutes the monitoring range can be expanded to include variables such as blood flow, volume responsiveness, afterload and contractility. The ProAQT®-Sensor is simply integrated into the existing blood pressure measurement system.

Clinical and Economic Benefits of ProAQT® 

  • Short-term advanced monitoring (TREND values)
  • Perioperative monitoring and fluid management of patients who are at high risk and/or having high risk interventions
  • Early recognition of unstable patients
  • Perioperative haemodynamic management as an instrument of Goal Directed Therapy (GDT)
  • Confirmed by NICE guidelines.

LiMON

Non-invasive monitoring of liver function or splanchnic perfusion.

LiMON is the Technology for non-invasive measurement of liver function and splanchnic perfusion monitoring, based on elimination of Indocyanine Green (ICG). Due to the fact that ICG is eliminated in the liver exclusively, the detection rate is a valuable indicator for global liver function. The diagnostic importance of the ICG detection as an indicator for the liver function has been confirmed in numerous scientific publications and has been established for more than 30 years.

Clinical benefits of LiMON 

  • Earliest detection of liver dysfunction
  • Reflects actual liver function
  • Non-invasive measurement
  • Available at the bedside

CeVOX Technology

Continuous monitoring of central venous oxygen saturation (ScvO2)

Continuous monitoring of central venous oxygen saturation (ScvO2) offers quick reacting information on the patients haemodynamic status. ScvO2 is much more sensitive than blood pressure and heart frequency for detecting shock status of any origin.

The indications for ScvO2 monitoring for early detection are:

  • Imbalance between oxygen supply and oxygen consumption
  • State of shock of any origin
  • Insufficient cardiac output (surrogate parameter)

Clinical Benefits of CeVOX:

  • Improve Patient Oxygenation
  • Improve Outcome by identifying  Hypoxia before it is too late
  • Early intervention- monitor acute changes in systemic balance between oxygen delivery and consumption
  • Reduce Mortality
  • Reduce length of stay
  • Simplify the workflow of nursing staff
  • Decrease number of complications

Features

Optimal readability

  • Brilliant 8″ LED colour screen with high resolution
  • Dark background and wide reading angle (>170°)

Easy to use

  • Glass touch screen and intuitive user interface
  • Individually adjustable parameter layout

Comfortable handling

  • Minimised dimensions and low weight
  • Flexible mounting and installation possibilities

Future-proof platform concept

  • Modular expandability with automatic module detection
  • Network compatible e.g. print function via hospital network

Made by

Visit website: